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Background: Infants born preterm commonly suffer from a combination of hypoxia-ischemia (HI) and infectious
perinatal inflammatory insults that lead to cerebral palsy, cognitive delay, behavioral issues and epilepsy. Using a
novel rat model of combined late gestation HI and lipopolysaccharide (LPS)-induced inflammation, we tested our
hypothesis that inflammation from HI and LPS differentially affects gliosis, white matter development and motor
impairment during the first postnatal month.
Methods: Pregnant rats underwent laparotomy on embryonic day 18 and transient systemic HI (TSHI) and/
or intra-amniotic LPS injection. Shams received laparotomy and anesthesia only. Pups were born at term.
Immunohistochemistry with stereological estimates was performed to assess regional glial loads, and western blots
were performed for protein expression. Erythropoietin ligand and receptor levels were quantified using quantitative
PCR. Digigait analysis detected gait deficits. Statistical analysis was performed with one-way analysis of variance and
post-hoc Bonferonni correction.
Results: Microglial and astroglial immunolabeling are elevated in TSHI + LPS fimbria at postnatal day 2 compared to
sham (both P < 0.03). At postnatal day 15, myelin basic protein expression is reduced by 31% in TSHI + LPS pups
compared to shams (P < 0.05). By postnatal day 28, white matter injury shifts from the acute injury pattern to a chronic
injury pattern in TSHI pups only. Both myelin basic protein expression (P < 0.01) and the phosphoneurofilament/
neurofilament ratio, a marker of axonal dysfunction, are reduced in postnatal day 28 TSHI pups (P < 0.001). Erythropoietin
ligand to receptor ratios differ between brains exposed to TSHI and LPS. Gait analyses reveal that all groups (TSHI, LPS
and TSHI + LPS) are ataxic with deficits in stride, paw placement, gait consistency and coordination (all P < 0.001).
Conclusions: Prenatal TSHI and TSHI + LPS lead to different patterns of injury with respect to myelination, axon
integrity and gait deficits. Dual injury leads to acute alterations in glial response and cellular inflammation, while
TSHI alone causes more prominent chronic white matter and axonal injury. Both injuries cause significant gait
deficits. Further study will contribute to stratification of injury mechanisms in preterm infants, and guide the use of
promising therapeutic interventions.
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In 2010, there were approximately 15 million preterm
births (gestation <37 weeks) worldwide. In most middle-
and high-income countries, preterm birth is the leading
cause of childhood death [1,2]. Beyond mortality, pre-
term birth can have extensive impact on neurodevelop-
ment, with increased risks of cerebral palsy, impaired
learning, vision and hearing loss, epilepsy, psychiatric
disorders and poor physical health. Together, these deficits
contribute to the prematurity-related burden of chronic
disease in adulthood [2,3]. Infants born extremely preterm
(<28 weeks gestational age) are particularly prone to
chronic neurological deficits, with up to one half ex-
periencing significant cognitive delay and behavioral
problems [4,5]. To identify and refine targets for new
therapeutic interventions, a clearer understanding of
how perinatal insults translate to impaired neurodeve-
lopment is imperative.
Central nervous system (CNS) injury associated with
preterm birth has multiple causes [6,7]. The risks of
neurological deficits are higher in preterm infants who
are also small for gestational age (weight <10% expected
for age) or who have associated perinatal infection [4,8-11].
Maternal smoking and higher placental resistance indices
are associated with increased risk of preterm or small for
gestational age births [12,13], and signs of maternal vascular
underperfusion in the placenta of extremely low gestational
age newborns (ELGANs) are associated with cerebral palsy
in childhood [14]. Conversely, acute chorioamnionitis is the
most common abnormality found in placentas from ex-
tremely preterm births [15]. Detailed analyses of placentas
from ELGANs show inflammation is more commonly asso-
ciated with spontaneous early birth, whereas less inflamma-
tion was present in placenta from births induced for
maternal health such as pre-eclampsia [16]. Intrauterine in-
fection increases the risk of cerebral palsy in children born
preterm [10,17,18], and recent well controlled studies have
confirmed that chorioamnionitis is associated with cerebral
palsy in children who were born very preterm [19], and
with cognitive impairment at 2 years in ELGANs [20]. To-
gether, these human studies of extremely preterm birth
reveal a strong correlation between in utero bacterial in-
flammation and hypoxia-ischemia (HI) and subsequent im-
paired brain development. These studies also suggest that
various types of injury, alone or in combination, may
impact the developing CNS via different mechanisms, and
thus require tailored neonatal cocktails of emerging neuro-
reparative interventions.
Systemic perinatal HI and inflammation appear to
act in concert to potentiate CNS damage from preterm
birth. For example, early hemodynamic disturbances
were present in very preterm newborns exposed to chor-
ioamnionitis and elevated cord blood cytokines [21], or
premature rupture of membranes [22], but not in theirpeers without these signs. In another prospective study,
the risk for abnormal neurologic outcome at 2 years was
highest for very preterm infants exposed to both histo-
logic chorioamnionitis and additional placental perfusion
defects [23]. Preclinical studies have demonstrated the
cumulative nature of HI and inflammatory insults to
the developing brain [24-31], but have not mimicked the
combined prenatal global HI injury with intrauterine
bacterial inflammation that directly models the extreme
preterm human condition. Significant overlap appears to
be present in the activation of aberrant signaling path-
ways induced by HI and bacterial inflammation. Our
limited understanding of the mechanisms underlying in
utero insults that adversely affect neurodevelopment fol-
lowing extremely preterm birth hinders the rational de-
sign and use of neonatal interventions to mitigate early
CNS injury. In particular, the impact on neurodevelop-
ment of coincident prenatal bacterial inflammation with
global HI remains to be defined for ELGANs.
Both the fetal CNS and immune system are develop-
mentally regulated. To more accurately mimic the brain
injury from extremely preterm birth in humans, we de-
veloped a clinically relevant rat model of in utero brain
injury that includes HI from placental perfusion dysfunc-
tion plus inflammation from bacterial chorioamnionitis
to investigate the response of the developing brain to HI
alone, inflammation alone or a dual HI-inflammatory in-
jury. Due to its high molecular weight, lipopolysacchar-
ide (LPS), the cell wall component of Gram negative
bacteria that initiates the inflammatory cascade, does
not cross the healthy placenta well, and the maternal
LPS-induced inflammatory response likely differs from
the immature fetal response. Because LPS has also re-
cently been found in cord blood in preterm infants with
chorioamnionitis [32], and microbial invasion of the pla-
centa is present in extremely preterm births [10], here
intra-amniotic injection of LPS was used to model the
fetal inflammatory response to bacteria. Transient sys-
temic HI (TSHI) via uterine artery occlusion on embry-
onic day 18 (E18), neurodevelopmentally equivalent to
approximately 25 weeks estimated gestational age (EGA)
in humans, induces white matter loss, gliosis and func-
tional deficits in adult rats [33], and premature loss of
the subplate [34] that mimics many aspects of the patho-
logical abnormalities observed in human post-mortem
samples from preterm infants with white matter lesions
[35,36]. Prenatal TSHI in rats also induces marked upreg-
ulation of the erythropoietin (EPO) receptor in the neo-
natal brain, leading to a mismatch of EPO ligand:receptor
signaling on neurons and oligodendrocytes [37,38]. We
hypothesized that prenatal TSHI plus intra-amniotic LPS
administration (TSHI + LPS) in rats would induce differ-
ent cellular, biochemical and functional effects on the
offspring, compared to prenatal LPS alone or TSHI alone.
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LPS leads to neonatal encephalomalacia and ventriculo-
megaly, acute chronic microgliosis and astrocytosis in
white matter, and decreased myelin basic protein (MBP)
expression, neurofilament (NF) ratio and motor deficits in
juvenile postnatal day 28 (P28) rats. The various prenatal
injuries also differentially affect the developmental regula-
tion of EPO ligand and receptor transcription levels. This
clinically relevant model will illuminate dissection of the
molecular pathways critical to the development of safe,
effective interventions for these vulnerable neonates.
Methods
Prenatal injury model
All procedures were performed in accordance with the
NIH Guide for the Care and Use of Laboratory Animals
and with the approval of the Institutional Animal Care
and Use Committee at Boston Children’s Hospital. Under
isoflurane anesthesia, a laparotomy was performed on
pregnant Sprague–Dawley rats on E18 (Figure 1A). For
TSHI, uterine arteries were occluded (Figure 1B) and after
60 minutes the clips were removed (Figure 1C). For the
combined injury, following 60 minutes of TSHI, 4 μg ster-
ile LPS (LPS 0111:B4, Sigma, St. Louis, MO) mixed with
diluted Evans blue dye (Sigma) was injected into each am-
niotic sac (Figure 1D). For LPS alone, LPS was injected
without transient uterine artery occlusion. For sham con-
trols, the laparotomy was performed and uterine horns
were exposed for 60 minutes, without artery occlusion or
LPS injection. Thus, all dams experienced an equivalent
time of laparotomy under anesthesia. Pups were born at
term (E22) and matured with their respective dams. Litter
size was recorded. Pups were weaned at P21. Pups were
weighed at the ages noted, and gender was recorded.
Overall, 12 sham, 16 TSHI, 7 LPS and 18 TSHI + LPS
dams were used.
Immunohistochemistry
Following a lethal dose of sodium pentobarbital, pups
were perfused at P2 (n = 4 to 6 per group) and P15
(n = 3 to 6 per group) and brains were processed for im-
munohistochemistry. Serial 20 μm coronal brain sections
were cut on a cryostat (Leica, Buffalo Grove, IL) from
the anterior frontal lobes through the posterior extent of
the dorsal hippocampus with sections mounted on slides
using stereology protocols. Blocking solution contained
10% normal goat serum and 0.1% triton in phosphate-
buffered saline. For microglia (ionized calcium-binding
adapter molecule 1; Iba1) and astrocyte (glial fibrillary
acidic protein; GFAP) immunohistochemistry, sections
were incubated with hydrogen peroxide treatment,
block, and then primary antibodies (Iba1, 1:500, Wako,
Cambridge, MA; and GFAP, 1:500, Dako, Carpenteria,
CA) overnight on sections at 4°C. The following daysections were washed, and incubated sequentially with
appropriate biotinylated secondary antibodies (1:200,
Vector, Southfield, MI), Vectastain (Vector), and diami-
nobenzadine, and mounted with Permount. Adjacent
sections were stained with H&E and mounted with
Permount. For MBP immunolabeling, after blocking,
sections were incubated with anti-MBP antibodies
(1:1000, Covance, Dedham, MA) overnight. The following
day, sections were washed and incubated with Alexa-Fluor
568 conjugated anti-mouse secondary antibodies (Life
Technologies, Grand Island, NY) for 1 hour. Sections
were then washed and coverslipped in an aqueous, DAPI-
containing mounting medium. Images were photographed
using consistent settings on a Leica microscope and
compiled in Photoshop (Adobe, San Jose, CA).Stereological estimates
All sections were coded prior to analysis to blind the
observer performing the counting. A Leica microscope
with a motorized stage and electronic microcator was
used with Stereologer software (Stereology Resource
Center, Tampa, FL) to perform the analyses. Lateral
ventricular volume was measured on P2 and P15 cor-
onal sections visualized with H&E using Cavalieri’s
method with the Stereologer software. Object area frac-
tion and volume probes were used to calculate load and
to quantify the amount of Iba1 + microglia and GFAP +
astrocytes as these cells change in number, size and
morphology following injury and through normal de-
velopment. Estimates of the load of each antigen were
obtained from 20 μm coronal sections using a thin sec-
tion modification of the optical fractionator method
[39,40]. Regions of interest (ROI) at P2 and P15 were
defined based on anatomical landmarks on coronal sec-
tions; the corresponding measurements from the adult
brain in Paxinos are noted only for the reader’s orienta-
tion [41]. In this study for the fimbria, the borders were
the following: anterior (anterior margin of the hippo-
campus, bregma -1.80), posterior (anterior margin of
the fasciola cinereum in the mesial hippocampus,
bregma -2.92), medial (thalamus), lateral (where the
fimbria abuts the lateral ventricle), superior (hippocam-
pus), and inferior (stria terminalis). The volume of the
ROI was calculated using Cavalieri’s method. Briefly,
the software superimposed a lattice of regularly spaced
plus-signs over the ROI, and the ROI was outlined on
every eighth section for P2 and every sixth section for
P15. The number of cells within each systematically
spaced unbiased sampling frame was counted, and the
coefficient of error were calculated and all <10%. At the
completion of the stereological analyses, the samples
were decoded, and mean and SEM of load were
calculated.
Figure 1 Combined intrauterine transient hypoxia-ischemia and intra-amniotic lipopolysaccharide in embryonic day 18 rats. (A) Under
isoflurane anesthesia, uterine arteries are exposed via midline laparotomy. (B) Occlusion and transient systemic hypoxia-ischemia (TSHI) is initiated
with placement of aneurysm clips on uterine arteries. (C) After 60 minutes of occlusion, blood is darker in both the vessels and the fetuses (black
arrows) and clips are removed. (D) Lipopolysaccharide (LPS), with Evans blue dye added to improve visualization (white arrows), is injected into
each amniotic sac. Shams undergo laparotomy and 60 minutes of anesthesia. (E) No significant difference in litter size was observed among the
various insult types (n = 8 to 37, mean ± SEM). (F) Fetal loss at postnatal day 0 (P0) is significantly increased in TSHI + LPS insult groups compared
to shams (n = 8 to 37, ***P < 0.001). (G) The various prenatal insults did not cause significant differences in weight at P28 (n = 8 to 30).
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Rat pups (n = 4 to 8/group/age) were euthanized by de-
capitation and P2 forebrain and P15 white matter was
dissected for transcriptional analyses using quantitative
PCR. Gene-of-interest primers and cDNA synthesized
from 0.9 μg RNA were added to Sybr green universal
MasterMix (Kapa, Wilmington, MA), and run intriplicate on a LifeTech Step-One Plus (Life Technologies,
Grand Island, NY). To standardize transcripts from
samples between experiments, cycle thresholds from
samples of interest were compared to cycle threshold
values from pooled E19 frontal cortex samples from
naïve pups, with gene-of-interest transcription normal-
ized to an 18 s endogenous control. The primers used
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Western blots
Western blots were performed on tissue homogenate
from microdissected white matter collected at P15 and
P28 following decapitation. After sonication, whole cell
proteins were isolated and a Bradford protein assay was
performed. Protein (30 μg) was loaded on 4 to 20% precast
Tris HCl or 4 to 12% Bis Tris gels (BioRad, Hercules,
CA). Following transfer to polyvinylidene fluoride
(PVDF) membranes, membranes were blocked and in-
cubated overnight at 4°C in anti-MBP (1:500, Millipore,
Darmstadt, Germany), anti-NF (1:1000, SMI-312, Cov-
ance), anti-phosphoNF (1:500, Millipore) or anti-actin
(1:5000, Sigma) antibodies. Following washes and incu-
bation with species-appropriate HRP-conjugated second-
ary antibodies, membranes were washed and incubated in
femto-West ECL and developed on a GE-LAS 4000
Digital image reader (GE Healthsciences, Pittsburgh, PA).
Resultant bands were quantified using GE ImageQuant
software (GE Healthsciences) and standardized to actin to
confirm equal protein loading among lanes.
Functional assessment
On P28 the gait of sham control (n = 18), LPS (n = 13),
TSHI (n = 14) and TSHI + LPS (n = 21) rats of both
sexes were quantified using the DigiGait™ Imaging Sys-
tem (Mouse Specifics, Inc., Boston, MA) [34]. All Digi-
Gait testing was performed in a blinded fashion and all
settings, including camera, lighting, shutter and belt
speed were optimized before experimental testing.
Briefly, a video camera mounted below a motorized
transparent treadmill belt captured the ventral side of
each rat while walking. Rats were placed on the treadmill
which was rapidly accelerated to 30 cm/second, the
speed at which the data is captured for analysis. The re-
corded output, including digital paw prints and dynamic
gait signals yielding the temporal record of paw place-
ment relative to the treadmill belt, was analyzed using
the DigiGait analysis software v.12.2 (Mouse Specifics,
Inc.). Numerous postural and kinematic metrics of gait
dynamics were determined by dissecting the time each
limb spent in various portions of the walking phase,Table 1 List of primers used for quantitative PCR
EPOR Forward: GAC CCC AGC TCT AAG CTC CT
EPOR Reverse: AGC CCC CTG AGC TGT AAT CT
EPO Forward: GCT CCA ATC TTT GTG GCA TC
EPO Reverse: ATC CAT GTC TTG CCC CCT A
18s Forward: TCC CTA GTG ATC CCC GAG AAG T
18s Reverse: CCC TTA ATG GCA GTG ATA GCG Aincluding paw area, paw placement during stance, stride
length, stepping frequency, and stride pattern [42]. Time
was measured in each phase of the walking stride (brake,
propel and swing) and gait consistency and coordination
were assessed. Forelimb and hindlimb data were taken
as the average measurement taken across the respective
left and right limbs [34,43].
Statistics and quantification
Data are presented as mean with SEM. Statistical ana-
lyses comparing treatment groups were performed
using a one-way analysis of variance (ANOVA) with
Bonferroni’s correction for multiple pairwise compari-
sons using IBM Statistics 21 (Armonk, NY, formerly
SPSS), with P < 0.05 considered significant.
Results
Impact of prenatal injury on overall health
We first evaluated fetal survival and pup growth follow-
ing the different types of insults. No differences in litter
size were observed at the time of laparotomy on E18 be-
tween the different lesion types (Figure 1E). Following
prenatal sham, LPS, TSHI, and TSHI + LPS insults on
E18, fetal loss at birth (P0) was markedly increased in
TSHI + LPS to 42% (one-way ANOVA, P < 0.001), com-
pared to 18% for LPS alone, 15% for TSHI alone, and 6%
after sham (Figure 1F). All pups that survived to P1
remained alive. Pups were weighed on P1, P5, P15 and
P28, and no significant weight differences were observed
between lesion types throughout the investigated time
course (Figure 1G). Thus, potential differences in func-
tional performance were not related to overall growth.
Prenatal injury impacts neonatal ventricular size
Neonatal ventriculomegaly is a common finding in neo-
nates born preterm with CNS injury. Histological exam-
ination of H&E stained brains at P2 revealed significant
ventriculomegaly and encephalomalacia following TSHI
and TSHI + LPS (Figure 2A). Specifically, at P2 both
TSHI and TSHI + LPS brains had significantly larger lat-
eral ventricles (4.0 ± 0.4 × 108 μm3, n = 5, P = 0.001 and
5.0 ± 0.1 × 108 μm3, n = 3, P = 0.01, respectively) com-
pared to shams (1.9 ± 0.4 × 108 μm3, n = 3, Figure 2B).
None of the rats at any age developed hydrocephalus
with macrocephaly. Note also that the subplate is visible
in the sham at P2 but is less apparent after the TSHI
and TSHI + LPS lesions (arrows in Figure 2A). With or
without the addition of LPS, prenatal TSHI caused
macroscopic cerebral changes at P2 consistent with
those observed in ELGANs with CNS injury.
Early glial response is altered by prenatal injury
Gliosis is another hallmark of CNS injury from preterm
birth. Immunolabeling and stereological analyses of P2
Figure 2 Prenatal transient systemic hypoxia-ischemia and/or intra-amniotic lipopolysaccharide leads to histological abnormalities on
postnatal day 2. (A) Coronal sections from shams and each of the three insults (lipopolysaccharide (LPS) alone, transient systemic hypoxia-ischemia
(TSHI) alone and TSHI + LPS) stained with H&E at P2 show the subplate (arrows) is present in shams, but less visible after the insults. Ventriculomegaly
and encephalomalacia are more prominent following prenatal TSHI and TSHI + LPS, compared to shams and LPS alone. Scale bar = 100 μm. (B) Lateral
ventricular volume is significantly larger in TSHI + LPS pups compared to shams (n = 3-5, ***P < 0.001). (C) Representative photomicrographs
depict increased ionized calcium-binding adapter molecule 1 (Iba1) immunoreactivity in the fimbria of TSHI + LPS pups. Scale bar = 100 μm.
(D) Similarly, Iba1 + load is significantly increased in TSHI + LPS pups compared to sham (n = 3-4, *P < 0.05). (E) In the fimbria, representative
photomicrographs show glial fibrillary acidic protein (GFAP) immunoreactivity is also increased in TSHI + LPS pups. Scale bar = 100 μm.
(F) GFAP + load in the fimbria is significantly increased in TSHI + LPS pups compared to sham (n = 3-4, **P < 0.01).
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loads in the fimbria of TSHI + LPS animals compared
to sham white matter, indicative of an acute cellular in-
flammatory response with microgliosis and astrocytosis,
respectively (Figure 2C,E). Specifically, Iba1 + load in
TSHI + LPS animals was 3.5 ± 0.3 × 106 (n = 3) com-
pared to 2.1 ± 0.2 × 106 in sham animals (n = 3, P =
0.025, Figure 2D). Similarly, GFAP + load in TSHI +
LPS animals was also significantly increased (9.7 ± 1.0 ×
106 versus 3.5 ± 0.6 × 106, n = 3, P = 0.003, Figure 2F). The
combined prenatal TSHI + LPS on E18 induced a glial re-
sponse that persisted 5 to 6 days until P2, equivalent to
approximately 32 weeks EGA in a human infant.Myelin basic protein expression is reduced at postnatal
day 15 after prenatal injury
To determine if the ventriculomegaly and gliosis per-
sisted beyond the acute period of injury, stereological
analyses of immunolabeling of Iba1 and GFAP were per-
formed at P15, approximately 19 days following the E18
lesion. While analyses revealed no significant differences
in ventricular volume (Figure 3A), Iba1 + load (Figure 3B)
or GFAP + load (Figure 3C) in the fimbria, a significant
reduction in MBP immunoreactivity was detected in the
corpus callosum and periventricular white matter of
pups suffering TSHI or the dual TSHI + LPS injury, com-
pared to sham pups (Figure 3D). MBP immunolabeling of
Figure 3 Myelin basic protein expression is decreased on postnatal day 15 following prenatal transient systemic hypoxia-ischemia
and/or lipopolysaccharide injury. (A) At postnatal day 15 no difference in lateral ventricle volume is observed (n = 3-6). (B,C) Similarly, stereological
investigations reveal ionized calcium-binding adapter molecule 1 (Iba1) + and glial fibrillary acidic protein (GFAP) + load in the fimbria are not
significantly different following the different types of prenatal insults (n = 3-4). (D) Myelin basic protein immunolabeling shows reduced protein
expression in the periventricular white matter of transient systemic hypoxia-ischemia (TSHI) and TSHI + lipopolysaccharide (LPS) pups compared
to shams. Scale bar = 100 μm.
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shown). To further quantify the MBP loss, western blots
were performed on white matter microdissected from P15
pups. Loss of MBP following in utero TSHI + LPS caused
a 31% reduction of MBP (0.69 ± 0.04, n = 12) compared to
sham levels (1.00 ± 0.08, n = 7, P = 0.047), whereas TSHI
alone led to only a partial (13%) decrease in MBP expres-
sion (0.87 ± 0.1, n = 10, P > 0.05). Similar to the immunola-
beling, LPS alone did not affect MBP protein expression
at P15 (data not shown). At P15 no differences in NF
levels, phosphoneurofilament (pNF) levels or pNF/NF ra-
tios were found amongst the injury types on western blots
(data not shown). Together, these results suggest that the
combined TSHI + LPS in utero injury on E18 causes loss
of MBP, a marker of myelination at P15, approximately
equivalent to a 2-year old toddler.
Prenatal transient systemic hypoxia-ischemia causes
chronic white matter and axonal injury
To determine whether the reduced expression of MBP ob-
served at P15 was transient or sustained, white matter was
also analysed at P28, a time point equivalent to an older
teenager when myelination is complete. These studies re-
vealed an apparent shift from an acute white matter injury
pattern with MBP loss in combined TSHI + LPS at P15 to
a different chronic injury pattern at P28 juvenile rats. Not-
ably, the chronic white matter injury pattern was presentin TSHI pups, but not observed in rats exposed to LPS. At
P28, TSHI pups had significantly decreased MBP protein
expression compared to shams (Figure 4A). Specifically,
P28 TSHI pups had a 28% reduction in MBP (0.72 ± 0.07,
n = 10) compared to sham animals (1.04 ± 0.10, n = 7, P =
0.038, Figure 4B). Analysis of the axonal proteins, NF and
pNF, corroborated MBP levels and revealed chronic
axonal injury was also present in TSHI pups. The ratio of
pNF/NF, a measure of axonal health, was markedly re-
duced at P28 in TSHI pups (0.79 ± 0.03, n = 9) compared
to shams (1.00 ± 0.04, n = 6, P = 0.005, Figure 4C), consist-
ent with the chronic loss of MBP observed at P28.
Interestingly, these results indicate prenatal TSHI
causes a more sustained white matter injury than pre-
natal LPS-induced inflammation, suggesting that LPS
and TSHI have differing mechanisms of injury that
cause varying patterns of injury to the immature white
matter and developing axons during the first month of
postnatal CNS maturation.
Injury impacts erythropoietin ligand and receptor mRNA
levels
EPO signaling influences the genesis, survival and mat-
uration of developing neural cells after prenatal injury,
primarily through the balance of the ligand and receptor
levels, which are transcriptionally regulated [37,38]. To
determine if the different in utero lesions altered postnatal
Figure 4 Myelin basic protein and neurofilament expression is significantly decreased in transient systemic hypoxia-ischemia pups on
postnatal day 28. (A) Following transient systemic hypoxia-ischemia (TSHI) on embryonic day 18, western blot analyses at postnatal day 28 reveal
protein expression of myelin basic protein (MBP), phosphoneurofilament (pNF), and neurofilament (NF) is significantly altered in microdissected white
matter. (B) MBP expression is significantly decreased in microdissected white matter from TSHI pups compared to sham levels (n = 3-10, **P < 0.01).
(C) Similarly, the ratio of pNF/NF is significantly decreased in TSHI pups compared to shams, indicative of axonal dysfunction (n = 4-13, ***P < 0.001).
LPS, lipopolysaccharide.
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of EPO and EPO receptor (EPOR) mRNA were per-
formed at P2 and P15. At P2, EPO ligand mRNA was
consistent across the injured groups compared to
shams (Figure 5A). In contrast, significant increases in
EPOR mRNA were observed in TSHI pups (2.0 ± 0.1, n = 7)
compared to sham controls (0.9 ± 0.1, n = 7, P = 0.001,
Figure 5A). The relative levels of mRNA expression had
shifted by P15 (Figure 5B). Levels of white matter EPO lig
and mRNA trended down following TSHI, while in the
presence of LPS-induced inflammation levels were stable,
without or with TSHI. Similarly, EPOR mRNA levels were
lower at P15 in the presence of LPS. As shown in
Figure 5C, the pattern of the EPO ligand:receptor ratio
shifted from P2 to P15. The ligand:receptor mismatch
and relative ligand deficiency persisted in TSHI pups
from P2 through P15, consistent with the reduced MBP
expression and pNF/NF ratio observed in white matter
from TSHI rats at P28. By contrast, in the presence of
LPS, the EPO ligand:receptor ratio stabilized by P15,
consistent with the lack of significant white matter
MBP and NF changes observed in LPS or TSHI + LPS
rats at P28. These data indicate that the impact of pre-
natal injury on EPO signaling may vary depending on
whether concurrent inflammation is present or not, andthat prenatal TSHI may induce a more severe, sus-
tained injury to the developing white matter. Further
detailed analyses are underway to clarify these complex
interactions.
Prenatal injury impacts motor function in juvenile rats
Consistent with the clinical picture of cerebral palsy and
spasticity in children suffering perinatal brain injury,
LPS (n = 13), TSHI (n = 14) and TSHI + LPS (n = 21) rats
showed functional gait abnormalities and postural in-
stability, including significant impairments in stride, ca-
dence, consistency and coordination compared to shams
(n = 18; Figure 6). Cumulatively, movement of the fore-
limbs and hindlimbs were abnormal, and most rats with
prenatal injury with all lesion types had difficulty with
coordinated stepping, as indicated by the reduced stride
length (Figure 6A), an increased coefficient in stride
length variation (Figure 6B), stride frequency (Figure 6E)
and ataxia (Figure 6F). Also, hindlimb time in the pro-
pel phase was reduced in TSHI and TSHI + LPS pups
(Figure 6C). Interestingly, TSHI and TSHI + LPS pups
exhibited evidence of toe walking consistent with spas-
tic gait hallmarked by significantly decreased paw area at
peak stance (Figure 6D). Similar to children with spasticity
from prematurity, the hindlimbs were affected more
Figure 5 Injury impacts erythropoietin ligand and receptor mRNA levels. (A) At postnatal day 2 (P2), erythropoietin receptor (EPOR) mRNA
levels are significantly higher in transient systemic hypoxia-ischemia (TSHI) pups compared to sham levels, without a concomitant increase in
erythropoietin (EPO) ligand mRNA levels (n = 5-14, ***P < 0.001). (B) By P15 no significant differences in EPO or EPOR mRNA exists between injury
groups (n = 3-7). (C) The patterns of the ratio of EPO ligand to EPO receptor shift from P2 to P15, with sustained ligand to receptor mismatch in
TSHI pups, in contrast to the shift observed in pups exposed to lipopolysaccharide (LPS) or TSHI + LPS. The persistent ligand deficiency correlates
with the sustained loss of myelin basic protein and the reduced phosphoneurofilament/neurofilament ratio observed at P28 in TSHI white matter,
but not LPS or TSHI + LPS white matter.
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the paw area (Figure 6D). While all injuries markedly af-
fected the gait, the presence of TSHI, with or without
LPS, produced more abnormalities. Subgroups analyses
for sex did not reveal sex-specific differences in the defi-
cits, except that females did not have decreased time in
the propel phase, and males did not have decreased paw
area at peak stance for any of the injury groups. Together,
these gait studies in juvenile rats demonstrate that pre-
natal injury induces persistent gait abnormalities with
similarities to the gait abnormalities found in children
with spasticity from preterm birth. More importantly,
these functional studies suggest that the various types of
prenatal injuries result in different gait abnormalities.
Discussion
Exposure of preterm infants to perinatal infection and
inflammation is associated with an increased risk for
neonatal brain damage and developmental disabilities
[6,7,9]. Here, using a clinically relevant rat model mimick-
ing brain damage from extreme preterm birth, we demon-
strate for the first time that the combination of in utero
TSHI and intra-amniotic LPS-induced inflammation resultsin cellular, biochemical and functional abnormalities in
1 month old rats. Moreover, we found that the various
types of prenatal injuries have differing, but consistent
and coherent patterns of impact on white matter devel-
opment, gait abnormalities and EPO signaling.
While it has been recognized for many years that in-
flammatory stimuli contribute to perinatal brain injury,
the pathophysiological mechanisms and models designed
to uncover those mechanisms have varied. Recent re-
ports indicate that chorioamnionitis can lead to a fetal
inflammatory response syndrome promoting a global in-
flammatory reaction and is a significant risk factor for
multiple complications in the preterm infant [44,45]. In
order to recapitulate the common clinical occurrence of
placental inflammation from intrauterine bacteria and
HI associated with very preterm birth, we added intra-
amniotic LPS administration to our previously published
rat model of prenatal TSHI that mimics injury at ap-
proximately 25 weeks EGA [33]. LPS is a non-infectious
cell wall component of Gram-negative bacteria that has
previously been introduced through various routes to in-
duce inflammation in the developing brain [24-26,46].
Activation of toll-like receptor 4 is triggered by LPS in a
Figure 6 Prenatal injury significantly impacts motor function in juvenile rats. Digigait analyses at postnatal day 28 demonstrate significant
motor impairment and gait abnormalities in both forelimbs and hindlimbs of lipopolysaccharide (LPS; n = 13), transient systemic hypoxia-ischemia
(TSHI; n = 14) and TSHI + LPS (n = 21) rats, compared to shams (n = 18). Impairment includes (A) decreased stride length, (B) increased stride variation,
(C) decreased time in the propel phase, (D) decreased paw area at peak stride, consistent with toe-walking, and (E) increased stride frequency, which
all culminate in (F) increased ataxia coefficients. *P < 0.05, ** P < 0.01, *** P < 0.001, versus shams. CV, Coefficient of variation.
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for initiation of neuronal injury from intrauterine LPS ex-
posure [48]. We found that the addition of intra-amniotic
LPS to in utero transient global HI on E18 results in ap-
proximately 44% fetal loss and causes encephalomalacia
with ventriculomegaly, and reactive astrocytosis and
microgliosis at P2, 1 week after the prenatal injury and
equivalent to approximately 30 to 32 weeks EGA. These
acute macroscopic and microscopic findings are con-
sistent with those observed in preterm infants with
white matter lesions [35,49,50].
By isolating the different types of injuries, we found
the pattern of white matter damage is complex and
evolves during the first postnatal month. While the ven-
triculomegaly and acute gliosis diminishes in this modelby P15, the approximate midpoint of myelination, loss of
MBP protein becomes apparent at P15 following both
TSHI alone and TSHI + LPS. At P15 the MBP loss is
more pronounced following the combined prenatal
TSHI + LPS injury than with TSHI alone. Interestingly,
analysis of juvenile rats at P28 indicated a shift in white
matter injury patterns whereby MBP loss persisted and
worsened in animals subjected to TSHI alone, consistent
with prior studies that showed prenatal TSHI causes
sustained loss of myelin in adults rats [33,37,51], and
hinders multiple stages of oligodendroglial lineage devel-
opment [33,38]. The MBP loss following prenatal TSHI
was accompanied by reduced pNF/NF ratio, consistent
with axonopathy observed in humans [52,53] and rats
with white matter lesions from prenatal ischemia [54].
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LPS present, and no reduction of pNF/NF occurred. To-
gether, these results support the hypothesis that prenatal
LPS-induced responses alter the pattern of white matter
injury differently compared to TSHI. These evolving pat-
terns of white matter injury during development are also
consistent with prior studies that showed two phases of
inflammatory response induced by LPS [55]. The evolv-
ing pattern of white matter injury in this rodent model
replicates the dysmaturation of white matter observed in
recent human imaging studies [56,57].
We next investigated whether the different patterns of
white matter injury induced by various prenatal injuries
correlated with functional outcomes using a detailed ana-
lysis of gait, since motor impairment manifesting as cere-
bral palsy, or developmental coordination disorder is a
common deficit in children born preterm [58]. In humans,
gait dynamics extend beyond measure of stride length
and, thus, we investigated additional metrics including
spatial and temporal gait indices [42]. Here, we report
chronic motor impairment, decreased stride length, in-
creased stride variation and decreased paw area in hin-
dlimbs consistent with toe-walking. As step-to-step gait
variability is common in humans with cerebral palsy, spas-
ticity and abnormalities of tone, we investigated ataxia co-
efficients and movement through the midline (an
indication of wobble and unsteadiness). We found rats
subjected to intra-amniotic LPS alone, TSHI alone and
TSHI + LPS each had significantly increased ataxia coeffi-
cients, increased stance variability and decreased stride
lengths. This postural instability and reductions in stance
duration may result in a shorter time for limb muscles to
be activated for stabilization [42,59], and may account for
the significant increases in stride-to-stride variability ob-
served in the injured animals. Consistent with previous re-
ports [43], and the clinical picture of spasticity and
cerebral palsy in children who are born preterm, measures
of hindlimb incoordination display more ataxic perturb-
ation than forelimbs. Stride length may be determined
predominantly by a gait-patterning mechanism, whereas
stance width may be determined by a balance-control
mechanism [42,60]. Although all three prenatal injuries
(LPS alone, TSHI alone and TSHI + LPS) caused similar
gait deficits in stride, posture and balance, the presence of
TSHI added additional deficits indicative of toe-walking,
reminiscent of the spastic gait observed in children born
preterm. The additional deficits found with TSHI are con-
sistent with the evidence of impaired myelination and axo-
nopathy discovered in our biochemical analyses at P28.
While caution must be used in extrapolating from bio-
chemical analyses and gait studies in young rats, our re-
sults support the hypothesis that the mechanisms of white
matter injury induced by HI and bacterial inflammation
likely overlap only partially.EPO has multiple mechanisms of neuroprotection that
may be beneficial to preterm infants, in part due to the
importance of EPO signaling during CNS development
and recovery from injury [61-63]. Indeed, a recent
multi-center trial demonstrated that very preterm infants
born at <1,250 g who were treated with erythropoiesis-
stimulating agents showed better cognition at 2 years
compared to placebo-treated infants [64]. Injury can in-
duce an excess of EPOR expression that is not matched
by a concomitant increase in ligand, resulting in excess
neural cell apoptosis [37]. Exogenous EPO treatment re-
stores the relative deficit in EPO ligand, mitigates the
EPO ligand:receptor mismatch and redirects neural cells
to survival and maturation [37,38]. Most studies in ro-
dents demonstrating sustained efficacy of EPO treatment
in the mature CNS following perinatal injury have used
HI [37,65-68]. EPO treatment has also shown long-term
efficacy in improving cognitive outcomes in rats with
bacterial meningitis [69], but no studies have investi-
gated the efficacy of EPO treatment in a dual injury
model. Consistent with the different patterns of white
matter injury and impaired gait with the different types
of lesions observed here, the ratio of EPO ligand to re-
ceptor was impacted differently by the various prenatal
insults over the first 3 postnatal weeks. Following pre-
natal TSHI the ratio of EPO:EPOR remained below
sham levels from P2 through P15, consistent with the
significant ligand deficit relative to receptor that has pre-
viously been found with prenatal TSHI [37]. By contrast,
the ratio of EPO:EPOR improved between P2 and P15
for the rats exposed to prenatal LPS. This pattern
change may correlate with the less severe white matter
injury observed at P28 in rats exposed to LPS or TSHI +
LPS, compared to TSHI alone, which showed sustained
loss of MBP expression and reduced pNF/NF ratios.
Consistent with the milder white matter injury observed
with the biochemical analyses at P28 in the rats exposed
to LPS, the gait abnormalities in the LPS-exposed rats
were also slightly milder. These milder biochemical and
functional deficits coincided with slightly higher EPO
ligand and lower EPOR transcription at P15 in the pres-
ence of LPS. Prior studies have found differences in the
inflammatory response depending on the age of the ani-
mal at the timing of the LPS and HI exposure
[24,27,47,55], which may be related to the maturation of
the toll-like receptor 4 signaling [47]. Here a combined
intrauterine insult was used to mimic a dual prenatal in-
sult that affects ELGANs, and compared to isolated pre-
natal LPS and HI insults. More extensive analyses are
needed to clarify whether the secondary phase of the re-
sponse to prenatal LPS exposure is less harmful than
prenatal HI. For numerous reasons care must be taken
with extrapolation from rodents to human neurodeve-
lopment, especially because of the critical role of the
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matic differences in the subplate between humans and
rodents [70,71]. These data suggest, however, that the
impact of prenatal injury varies depending on whether
inflammation is present or not, and that early HI may
induce a more severe, persistent injury to the developing
white matter. Together, these results support the devel-
opment of specific clinically feasible and safe biomarkers
to guide the use of emerging neuroprotective agents for
critically ill preterm infants in real-time. Preterm infants
who suffer HI may need a different treatment paradigm
than those exposed to bacterial inflammation, or a com-
bined injury. Indeed, hypothermia, a neuroprotective
therapy used in term infants with HI injury, was found
not to be effective when P7 rat pups were pretreated
with LPS prior to the HI insult [72]. Additional studies
are also needed to clarify the impact of cumulative post-
natal HI or infectious insults on the developing brain.
Clarification of injury mechanisms with clinically rele-
vant models such as presented here will advance our
treatment regimens and ultimately improve outcomes
for ELGANs.
Conclusions
Prenatal LPS, TSHI and TSHI + LPS lead to different pat-
terns of injury with respect to white matter injury, as shown
by myelination and axon integrity, gait deficits and EPO
signaling. Dual injury leads to acute alterations in glial re-
sponse and cellular inflammation, while TSHI alone causes
chronic white matter and axonal injury. Both injuries cause
significant gait deficits, although with different patterns.
Both injuries also alter the transcriptional regulation of
EPO ligand and receptor during the neonatal period. Fur-
ther study will contribute to stratification of injury mecha-
nisms in preterm infants, and guide the use of promising
therapeutic interventions.
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